Share Your Cancer Drug Story With Us
Sometimes insurers balk at covering cancer drugs that might help patients whose tumors have certain molecular markers. This can happen because the specialist groups that insurers usually rely on for their coverage decisions haven’t yet incorporated the latest scientific research on cancer genetics.